BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 11134302)

  • 1. Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays.
    Jenner RG; Albà MM; Boshoff C; Kellam P
    J Virol; 2001 Jan; 75(2):891-902. PubMed ID: 11134302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissection of the Kaposi's sarcoma-associated herpesvirus gene expression program by using the viral DNA replication inhibitor cidofovir.
    Lu M; Suen J; Frias C; Pfeiffer R; Tsai MH; Chuang E; Zeichner SL
    J Virol; 2004 Dec; 78(24):13637-52. PubMed ID: 15564474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of the open reading frame 35 encoded by Kaposi's sarcoma-associated herpesvirus.
    Masa SR; Lando R; Sarid R
    Virology; 2008 Feb; 371(1):14-31. PubMed ID: 17963810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis.
    Viejo-Borbolla A; Schulz TF
    AIDS Rev; 2003; 5(4):222-9. PubMed ID: 15012001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-HIV agent MAP30 modulates the expression profile of viral and cellular genes for proliferation and apoptosis in AIDS-related lymphoma cells infected with Kaposi's sarcoma-associated virus.
    Sun Y; Huang PL; Li JJ; Huang YQ; Zhang L; Huang PL; Lee-Huang S
    Biochem Biophys Res Commun; 2001 Oct; 287(4):983-94. PubMed ID: 11573962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lytic induction of Kaposi's sarcoma-associated herpesvirus in primary effusion lymphoma cells with natural products identified by a cell-based fluorescence moderate-throughput screening.
    Cho HJ; Yu F; Sun R; Lee D; Song MJ
    Arch Virol; 2008; 153(8):1517-25. PubMed ID: 18607675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
    Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
    Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus.
    Cathomas G
    Herpes; 2003 Dec; 10(3):72-7. PubMed ID: 14759339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of cell signaling pathways by Kaposi's sarcoma-associated herpesvirus (KSHVHHV-8).
    Damania B
    Cell Biochem Biophys; 2004; 40(3):305-22. PubMed ID: 15211030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of oncogenic viral interferon regulatory factor (vIRF) of Kaposi's sarcoma-associated herpesvirus by ribozyme-mediated cleavage.
    Zhang YJ; Wang XP; Deng JH; Salinas RA; Oishi N; Gao SJ
    Cancer Gene Ther; 2001 Apr; 8(4):285-93. PubMed ID: 11393281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pleiotropic effects of Kaposi's sarcoma herpesvirus.
    Schulz TF
    J Pathol; 2006 Jan; 208(2):187-98. PubMed ID: 16362980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.
    Liang Y; Ganem D
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8490-5. PubMed ID: 12832621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression.
    Vieira J; O'Hearn PM
    Virology; 2004 Aug; 325(2):225-40. PubMed ID: 15246263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms governing expression of the v-FLIP gene of Kaposi's sarcoma-associated herpesvirus.
    Grundhoff A; Ganem D
    J Virol; 2001 Feb; 75(4):1857-63. PubMed ID: 11160684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
    Lan K; Murakami M; Choudhuri T; Kuppers DA; Robertson ES
    Virology; 2006 Aug; 351(2):393-403. PubMed ID: 16701788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttranscriptional gene regulation in Kaposi's sarcoma-associated herpesvirus.
    Conrad NK
    Adv Appl Microbiol; 2009; 68():241-61. PubMed ID: 19426857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch signal transduction induces a novel profile of Kaposi's sarcoma-associated herpesvirus gene expression.
    Chang H
    J Microbiol; 2006 Apr; 44(2):217-25. PubMed ID: 16728959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydrofolate reductase from Kaposi's sarcoma-associated herpesvirus.
    Cinquina CC; Grogan E; Sun R; Lin SF; Beardsley GP; Miller G
    Virology; 2000 Mar; 268(1):201-17. PubMed ID: 10683342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human herpesvirus 8 open reading frame 26 and open reading frame 65 sequences from multiple myeloma patients: a shared pattern not found in Kaposi's sarcoma or primary effusion lymphoma.
    Ma HJ; Sjak-Shie NN; Vescio RA; Kaminsky M; Mikail A; Pold M; Parker K; Beksac M; Belson D; Moss TJ; Wu CH; Zhou J; Zhang L; Chen G; Said JW; Berenson JR
    Clin Cancer Res; 2000 Nov; 6(11):4226-33. PubMed ID: 11106236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Kaposi's Sarcoma-Associated Herpesvirus ORF21 Tyrosine Kinase and Viral Lytic Reactivation by Tyrosine Kinase Inhibitors Approved for Clinical Use.
    Beauclair G; Naimo E; Dubich T; Rückert J; Koch S; Dhingra A; Wirth D; Schulz TF
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31826996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.